Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$201360.0.

  • Bioadaptives' Other Non Operating Income fell 31423.78% to -$201360.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$43196.0, marking a year-over-year increase of 9059.82%. This contributed to the annual value of -$297071.0 for FY2024, which is 3856.39% up from last year.
  • Latest data reveals that Bioadaptives reported Other Non Operating Income of -$201360.0 as of Q3 2025, which was down 31423.78% from $130954.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Other Non Operating Income ranged from a high of $261488.0 in Q3 2023 and a low of -$278011.0 during Q1 2021
  • Moreover, its 5-year median value for Other Non Operating Income was -$87968.0 (2023), whereas its average is -$74731.6.
  • Per our database at Business Quant, Bioadaptives' Other Non Operating Income tumbled by 2108123.08% in 2023 and then skyrocketed by 24544.14% in 2025.
  • Over the past 5 years, Bioadaptives' Other Non Operating Income (Quarter) stood at -$36549.0 in 2021, then soared by 97.33% to -$975.0 in 2022, then crashed by 21081.23% to -$206517.0 in 2023, then skyrocketed by 83.32% to -$34449.0 in 2024, then plummeted by 484.52% to -$201360.0 in 2025.
  • Its last three reported values are -$201360.0 in Q3 2025, $130954.0 for Q2 2025, and $61659.0 during Q1 2025.